Alan Long
Impact in
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
-
- IL-33, ST2, and ILC Pathways 3
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 1
- T-cell and B-cell Immunology 1
- Co-authors
- Siqi Chen (7 shared papers)Jie Fan (7 shared papers)Donye Dominguez (7 shared papers)Lei Qin (7 shared papers)Bin Zhang (6 shared papers)Yi Zhang (6 shared papers)DeYu Fang (4 shared papers)Timothy Michael Kuzel (4 shared papers)
- Journals
- The Journal of Immunology (3 papers)Frontiers in Immunology (1 paper)Nature Communications (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Alan Long
8 papers receiving 436 citations
Peers
Comparison fields: 5 of 45
- Immunology 236
- Physiology 46
- Oncology 105
- Molecular Biology 74
- Cancer Research 13
Countries citing papers authored by Alan Long
This map shows the geographic impact of Alan Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Long more than expected).
Fields of papers citing papers by Alan Long
This network shows the impact of papers produced by Alan Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Long. The network helps show where Alan Long may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | 2019 | 82 | |
| 3 | 2018 | 64 | |
| 4 | 2015 | 63 | |
| 5 | 2016 | 50 | |
| 6 | 2021 | 35 | |
| 7 | 2020 | 33 | |
| 8 | 2017 | 30 |
About Alan Long
Alan Long is a scholar working on Immunology, Physiology, Oncology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 443 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (1 paper), Immune cells in cancer (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Cancer-related Molecular Pathways (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Immunology (236 citations), Physiology (46 citations), Oncology (105 citations), Molecular Biology (74 citations) and Cancer Research (13 citations). Alan Long has collaborated with scholars based in United States and China. Frequent co-authors include Siqi Chen, Jie Fan, Donye Dominguez, Lei Qin, Bin Zhang, Yi Zhang, DeYu Fang, Timothy Michael Kuzel, Cong Ye and Jeong Ah Park. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, Nature Communications, Journal for ImmunoTherapy of Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.